Quick Summary
Retatrutide is a triple agonist (GLP-1 + GIP + Glucagon), while Tirzepatide is dual (GLP-1 + GIP).
Retatrutide shows superior fat loss in trials — up to 24% total body weight vs 21% with Tirzepatide.
Both are long-acting and dosed weekly, but Retatrutide may offer greater energy expenditure and thermogenesis.
Peptides Lab UK…
Quick Summary
Retatrutide is a triple agonist peptide (GLP-1, GIP, Glucagon) under active investigation.
Preclinical trials show dose-dependent fat loss, metabolic, and appetite-regulation benefits.
Titration protocols start low (1mg) and increase gradually for best results.
Peptides Lab UK offers high-purity, COA-verified Retatrutide for research purposes only.
What Is Retatrutide and Why Dosage Matters
Retatrutide is…
Buy Peptides Lab UK